Sana Benefits Closes $20.8M Series A Funding Round to Disrupt the ‘Big 5’ Health Insurance Monopoly
SciClone Pharmaceutical (Holdings), a Chinese biopharmaceutical company that claims to have developed a drug to treat Covid-19, is seeking the greenlight to list in Hong Kong.
Investment bank Houlihan Lokey has added Keith Barry to its team as a managing director and the head of medical technology, a new practice within the firm’s healthcare group. Mr. Barry joins Allan Burton who
GI Partners has held a final closing of its inaugural Data Infrastructure Fund LP, with $1.8 billion in capital. The new fund was oversubscribed and beat its target of $1.25 billion. Investors in the Data
BIMA, a Stockholm-based provider of digital health and insurance technology services in emerging markets, has raised $30m from Chinese fintech investor CreditEase Fintech Investment Fund (CEFIF) and existing backers Leapfrog Investments and Allianz.
InsurTech BIMA has raised a $30m round with the goal of using the money to drive mass adoption of digital health and InsurTech solutions in emerging markets.
The bill would have given the state attorney general the power to block acquisitions by investment firms
Healthcare technology investor Heal Capital has led a series-A funding round for computer-brain-interface specialist CereGate.
KICTeam, a portfolio company of Inverness Graham since May 2020, has acquired Teknipure, a maker of c. Teknipure is a manufacturer and distributor of products used to prevent, control, and remove contaminants from cleanrooms and
Webster Equity Partners is reportedly eyeing up to $1bn for healthcare investments through the raise of its debut fund solely dedicated to the sector.
Graycliff Partners has acquired its first fund four platform with the buy of Gerard Daniel Worldwide. Gerard Daniel is a manufacturer and distributor of more than 5,000 SKUs of wire mesh and other wire products
Clayton, Dubilier & Rice (CD&R) has agreed to acquire Epicor Software from KKR in a transaction valued at $4.7 billion. KKR purchased Epicor in July 2016 from Apax Partners at an enterprise value of $3.3
Claris Ventures has held a €30m first close for its debut fund, Claris Biotech I, which is dedicated to investments in biopharmaceutical startups in pre-clinical phase.
Rapidly following its buy of Divisions Maintenance Group earlier this month, Roark Capital has now made an investment in US Sports Camps. According to Roark, US Sports Camps (USSC) is the nation’s leading youth sports
Healthcare-focused private equity firm ArchiMed has acquired a majority stake in NAMSA, a contract research organisation for medical devices, from the founding Gorski Family.
Private equity firm Nexxus Iberia has acquired a controlling stake in Portuguese radiotherapy specialist Mercurius Health.
